News

HIV prevention drug lenacapavir approved by FDA as twice-yearly injection
Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...
FDA announces sweeping changes to speed up the drug review process
An FDA pilot program, known as the Commissioner’s Priority Voucher program, could drastically change the way pharmaceutical ...
Little Remedies Honey Cough Syrup recalled over safety concerns
The recall affects 4 oz. bottles of the natural cough syrup distributed across the United States between December 2022 and ...
The Columbian43m
FDA approves the world’s only twice-a-year shot to prevent HIV
The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday. It’s the first step in an anticipated global rollout that could protect ...
STAT48mOpinion
Following second patient death, Duchenne muscular dystrophy families deserve answers about Elevidys
Duchenne muscular dystrophy families are sharing stories about Elevidys complications on social media. But they aren’t ...
FDA offers speedier approvals to drug companies aligning with 'national priorities'
On Tuesday, the U.S. Food and Drug Administration announced a new initiative to offer expedited reviews for new medicines, an ...
Nuvation Bio - A Justified Fall Based On Post Marketing Requirements
Nuvation Bio's FDA approval for IBTROZI isn't boosting its stock. Learn about NUVB's financial risks, valuation concerns, and ...
FDA Approves Powerful Twice-Yearly Treatment to Prevent HIV
Gilead’s Yeztugo will offer an alternative to treatments such as daily pills and every-other-month injections.
FDA’s removal of Ozempic, Wegovy from drug shortage list upheld
A federal judge on Wednesday ruled that the Food and Drug Administration’s (FDA) decision to remove popular GLP-1s from its drug shortage list, ending the sale of compounded versions of the ...